The Deep South Resource Center for Minority Aging Research onboards Reagan W. Durant, MD, associate professor at the University of Alabama at Birmingham’s Division of Preventative Medicine. Dr. Durant will serve as a new principal investigator.
The Deep South RCMAR
A collaborative partnership including Morehouse School of Medicine, Tuskegee University, the University of Alabama and UAB, focuses on minority aging research with a disparities concentration, especially related to problems prevalent among older African Americans living in both rural and urban areas.
This program is funded by the National Institute of Aging
The program offers various training and career development programs for early-career or transitional scientists, such as the Pilot Grant Program and Diversity Supplements. The RCMAR program also sponsors trainees from all four sites to participate in the UAB Health and Health Disparities Center Health Disparities Research Education Program, which includes didactic lectures on health disparities as well as grant-and manuscript writing retreats.
After joining UAB faculty in 2006, Durant was one of the RCMAR’s original scientists, formerly known as RCMAR scholars. He has continued to support programs since then, serving in many roles such as mentor, pilot grant reviewer, co-chair of the Scholar Advisory Group, and co-chair of the Community Liaison and Recruitment Core.
Durant is the medical director of Cooper Green Mercy Health Services and a Board member of the newly formed Cooper Green Mercy Health Services Authority. Durant has served and participated in a number of review committees for prominent scientific journals, including the Journal of the American Medical Association and the Journal of General Internal Medicine.
RCMAR engages in various research initiatives with a focus on mobility, urinary and fecal incontinence, Alzheimer’s disease and related memory problems, nutrition, geriatric heart failure, end-of-life care, advanced illness management, functional outcomes of geriatric health care and quality improvement.
They also engage in basic biomedical research initiatives such as cellular and molecular mechanisms involved in atherosclerosis and Alzheimer’s disease—including the role of monocytes and macrophages, endothelial cells, apolipoproteins, dietary factors, and the anti-atherosclerotic and anti-inflammatory activity of peptide mimics of apolipoproteins.
Reagan W. Durant, MD